Latest Commercialization News

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

Metallium Limited and Ucore Rare Metals have entered a binding 12-month collaboration to integrate their cutting-edge technologies, aiming to establish the first fully U.S.-based rare earth element refining pathway and reduce reliance on Chinese supply chains.

Next Science has finalised the sale of nearly all its assets to OSARTIS GmbH for US$50 million, with plans to return approximately US$30 million net proceeds to shareholders following legal and tax review.

CSL Limited has partnered with Dutch biotech VarmX to develop VMX-C001, a novel treatment aimed at reversing bleeding in patients on FXa inhibitors, with FDA Fast Track status and a potential 2029 launch.

Marvel Gold Limited has significantly increased its landholding in Tanzania’s Iramba-Sekenke Greenstone Belt, acquiring two new prospecting licences and applying for a third, setting the stage for a maiden drilling campaign.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

Northern Minerals has released its Definitive Feasibility Study for the Browns Range Heavy Rare Earth Project, confirming an 11-year production plan targeting 181,000 tonnes of rare earth concentrate. The project aims to establish a critical Australian supply chain for heavy rare earths in partnership with Iluka Resources.

TMK Energy has successfully raised $3.5 million through an oversubscribed placement, setting the stage for commercial production and exploration at its Gurvantes XXXV Coal Seam Gas Project.

Artrya Limited has completed the first tranche of its A$75 million placement, raising approximately A$60 million to advance its AI-driven coronary artery disease platform. Eligible shareholders can now participate in a Share Purchase Plan at the same price.

Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.

Kinetiko Energy has achieved a record peak gas flow from its latest production test well at Brakfontein, significantly surpassing previous results and advancing its pilot LNG project in South Africa.